Obstructive Sleep Apnea and Cardiovascular Disease
Published: June 21, 2021
- Obstructive Sleep Apnea (OSA) is widely under-diagnosed - 86 to 95% of individuals found in population surveys with clinically significant OSA report no prior OSA diagnosis.
- Sleep disturbances are common and underdiagnosed among middle-aged and older adults and the prevalence varies by race/ethnicity, sex, and obesity status.
- OSA is associated with reduced survival rates in epidemiological studies. Severe OSA is associated with an increased all-cause and cardiovascular mortality.
Supporting Materials
- Commentary: Obstructive Sleep Apnea, An Underappreciated Crisis in Cardiovascular Disease by David E. Winchester, MD, MS, FACC, FASNC, FACP
- Top Things to Know: Obstructive Sleep Apnea and Cardiovascular Disease
Recommended Reading
- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
- 2017 Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- 2019 Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- 2019 Guideline on the Primary Prevention of Cardiovascular Disease
- 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults